-+ 0.00%
-+ 0.00%
-+ 0.00%

*ProKidney On Track to Complete Enrollment for Phase 3 PROACT 1 Accelerated Approval Analysis of Rilparencel in Mid-2026 >PROK

Dow Jones·03/18/2026 20:16:00

Please log in to view news